Pin on Pinterest

The global bovine mastitis market size reached USD 0.60 billion in 2023 and is expected to climb to USD 0.98 billion by 2031, exhibiting a steady Compound Annual Growth Rate (CAGR) of 6.4% from 2024 to 2031. This press release explores key factors influencing market growth, regional analysis, and crucial takeaways for industry stakeholders.

Key players

Some major key players in Bovine Mastitis Market are Oncothyreon Inc, Bayer AG, Zoetis Inc., OncoGenex, Boehringer Ingelheim GmbH, Pfizer Inc., Apthera Inc., Merck Co. & Inc., Astellas Pharma Inc., Novartis AG and other players.

Market Analysis

The bovine mastitis market is primarily driven by the expanding dairy industry and increasing awareness of mastitis treatment and prevention methods. Mastitis, an inflammatory udder disease in cows, significantly impacts milk production and quality. Rising consumer demand for dairy products like milk, cheese, and yogurt is propelling the need for healthy dairy herds, thereby fueling market growth for mastitis control solutions.


By Product

  • Antibiotics

  • Other

By Route of Administration

  • Systemic

  • Intramammary

By Application

  • Veterinary Clinics and Hospitals

  • On-site Treatment


Impact of the Russia-Ukraine Conflict

The ongoing conflict between Russia and Ukraine has disrupted global supply chains for essential agricultural products and veterinary medicines. This disruption may lead to temporary price fluctuations and shortages of bovine mastitis treatment products in certain regions. However, the long-term impact is expected to be minimal as alternative suppliers emerge and markets adapt.

The Impact of Economic Slowdown

An economic slowdown could potentially limit dairy farm investments in advanced mastitis detection and treatment technologies. However, the essential nature of mastitis control for maintaining milk production is likely to mitigate this effect. Farmers are expected to prioritize cost-effective solutions to ensure herd health and milk quality.

Regional Analysis

The Asia-Pacific region currently holds the dominant share of the bovine mastitis market due to the burgeoning dairy sector in countries like India and China. Additionally, growing awareness of animal health and increasing disposable income in these regions are expected to contribute to further market expansion. North America and Europe are also significant markets with established dairy industries and a focus on advanced mastitis management practices.

Key Takeaways

  • The rising demand for dairy products and growing awareness of mastitis treatment are key drivers of the bovine mastitis market.
  • The Russia-Ukraine conflict may cause temporary disruptions, but the long-term impact is expected to be manageable.
  • Economic slowdown may influence farmers' investment decisions, but essential mastitis control solutions are likely to remain prioritized.
  • The Asia-Pacific region is expected to maintain its dominance, with significant growth potential in other regions as well.

This market presents a promising opportunity for companies offering innovative and cost-effective solutions for bovine mastitis prevention, diagnosis, and treatment.

Other Trending Report

Recombinant Vaccines Market Size

Ureteroscope Market Size

Wound Care Devices Market Size

Scoliosis Management Market Size

Dermatology Drugs Market Size

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)